| ²é¿´: 585 | »Ø¸´: 3 | ||
»Ø¹é×ÔÈ»½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
Õâ¾ä»°ÈçºÎ׼ȷ·Òë
|
| Thus, the face-to-face comparison of studies looking at vascular calcifications with those focusing on a solid clinical end point (mortality) indicates that vascular calcifications do not reflect the underlying risk for death in haemodialysis patients treated with a non-calcium phosphate binder (sevelamer) or with cinacalcet. |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
294Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
322Çóµ÷¼Á£ºÒ»Ö¾Ô¸ºþÄÏ´óѧ ²ÄÁÏÓ뻯¹¤£¨085600£©£¬ÒѹýÁù¼¶¡£
ÒѾÓÐ14È˻ظ´
282Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
µ÷¼Á
ÒѾÓÐ9È˻ظ´
315Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ8È˻ظ´
070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
ssssllllnnnn
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
Translator and Proofreader
- ·ÒëEPI: 1690
- Ó¦Öú: 452 (˶ʿ)
- ½ð±Ò: 31580.9
- ºì»¨: 100
- Ìû×Ó: 7681
- ÔÚÏß: 19966.6Сʱ
- ³æºÅ: 3328089
- ×¢²á: 2014-07-17
- רҵ: Ö×Áö·¢Éú
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
»Ø¹é×ÔÈ»: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2015-09-17 22:17:55
»Ø¹é×ÔÈ»: ½ð±Ò+5, ¡ï¡ï¡ïºÜÓаïÖú 2015-09-17 22:17:55
| Òò´Ë£¬Ö±½Ó£¨Ãæ¶ÔÃæ£©±È½ÏÄÇЩ¹Û²ìѪ¹Ü¸Æ»¯µÄÑо¿ÓëÄÇЩ¼¯ÖÐÓÚ²¡ÈËÁÙ´²Öյ㣨ËÀÍö£©µÄÑо¿±íÃ÷£¬ÔÚÓ÷ÇÁ×Ëá¸Æ½áºÏ¼Á£¨Ë¾Î¬ÀÄ·£©»òÎ÷ÄÇ¿¨ÈûÖÎÁƵÄѪ͸»¼ÕßÖУ¬Ñª¹Ü¸Æ»¯²¢²»ÊÇ£¨·´Ó³£©²¡ÈËËÀÍöµÄµÄ»ù±¾·çÏÕÒòËØ¡£ |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
2Â¥2015-09-17 01:11:09
»Ø¹é×ÔÈ»
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 28 (СѧÉú)
- ½ð±Ò: 1023.1
- É¢½ð: 505
- ºì»¨: 6
- Ìû×Ó: 258
- ÔÚÏß: 35.5Сʱ
- ³æºÅ: 3781831
- ×¢²á: 2015-04-02
- ÐÔ±ð: GG
- רҵ: Ô·¢ÐÔÉöÔ༲²¡
3Â¥2015-09-17 06:48:44
»Ø¹é×ÔÈ»
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 28 (СѧÉú)
- ½ð±Ò: 1023.1
- É¢½ð: 505
- ºì»¨: 6
- Ìû×Ó: 258
- ÔÚÏß: 35.5Сʱ
- ³æºÅ: 3781831
- ×¢²á: 2015-04-02
- ÐÔ±ð: GG
- רҵ: Ô·¢ÐÔÉöÔ༲²¡
4Â¥2015-09-17 07:04:18














»Ø¸´´ËÂ¥
»Ø¹é×ÔÈ»